---
truth_dimension: orientation
authority_level: advisory
mutation_path: readme_update
---

# Repository Audit Report - Phase 25

Date: 2026-05-03
Scope: Roadmap/changelog alignment and repository audit maintenance check.

## Passed checks

- Roadmap and changelog alignment confirmed: `CHANGELOG.md` records completed phases through v0.0.24, while `docs/roadmap/phase-map.md` remains planned truth without completed-status claims.
- Planned sequencing still resumes from the post-v0.0.19 state and keeps Phase 26 as the next implementation phase.
- Roadmap includes required alignment anchors: Phase 19.5 historical implementation note, planned-sequence divider, Phase 25 and 26 entries, Phase 30 and Phase 35 alignment checks, and recurring roadmap/changelog alignment requirement.
- UI remains read-only and fixture-backed; required scans found no fetch/storage/socket/timer behavior.
- No Rust, TypeScript behavior, schema, workflow, governance, or architecture changes were introduced in this phase.
- Validation commands succeeded (`./scripts/check.sh`, UI typecheck/lint/build).

## Minor findings

- UI scan keywords (`promot`, `execute`, `delete`, `disable`, `rebuild`, `reject`) match read-only fixture fields and explanatory text in UI screens, not active mutation controls.
- Placeholder/stub language appears across bootstrap-era scripts/docs/checklists and UI placeholder text; this is consistent with current repository stage and does not indicate authority leakage.
- Enforcement-risk phrase scan (`force`, `skip policy`, `skip validation`, `promote anyway`, `trust output`, `ignore unknown`) matches roadmap/governance wording used as prohibitions or checks, not executable bypass logic.

## Required follow-ups

- None required within Phase 25 scope.
- Continue recurring roadmap/changelog alignment checks at defined cadence (next alignment checkpoint remains planned at Phase 30).

## Deferred items

- Any future runtime, UI behavior, schema, or workflow remediations must be handled in explicitly scoped implementation or maintenance phases if new non-harmless findings appear.

## Confirmed vs suspected

- Confirmed: alignment status, scan outputs, and validation outcomes above were directly verified.
- Suspected risks: none elevated in this phase beyond normal placeholder-surface maturation risk already represented in planned sequencing.
